GLYCOMIMETICS
GlycoMimetics, Inc., a biopharmaceutical company, engages in the design and development of small molecule therapeutics to mimic the functions of bioactive carbohydrates. Its products include GMI-1070, a synthetic glycomimetic molecule designed to inhibit selectin types, such as E, P, and L-selectin; and GMI-1051, a small molecular weight compound for the treatment or prevention of infections caused by pseudomonas aeruginosa. The company was founded in 2003 and is based in Gaithersburg, Maryland.
GLYCOMIMETICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2003-01-01
Address:
Gaithersburg, Maryland, United States
Country:
United States
Website Url:
http://www.glycomimetics.com
Total Employee:
51+
Status:
Active
Contact:
2402431207
Total Funding:
194.38 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon WordPress Google Universal Analytics Font Awesome
Similar Organizations
Adamis Pharmaceuticals
Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.
Ampio Pharmaceuticals
Ampio Pharmaceuticals is a biopharmaceutical firm that discovers and develops novel therapies for treating inflammatory conditions.
Calithera Biosciences
Calithera Biosciences is a pharmaceutical company developing novel small molecule therapeutics for the treatment of cancer.
Epirium Bio
Epirium Bio is a biopharmaceutical company developing a small molecule platform targeting improvements in muscle strength.
Cascadian Therapeutics
Cascadian Therapeutics is a bio-pharmaceutical company that researches, develops, and sells therapeutic products for treatment of cancer.
CTI BioPharma
CTI BioPharma is a biopharmaceutical company developing oncology products for the treatment of cancer.
Innovation Pharmaceuticals
Innovation Pharmaceuticals is a biopharmaceutical company developing small molecule therapies in areas of unmet medical needs.
Celsion
Celsion is a biopharmaceutical company which develops innovative, targeted therapies that address unmet medical needs in oncology.
Celtaxsys
Celtaxsys is a biopharmaceutical company, engages in developing and testing drug compounds for treating cancer.
Cequent Pharmaceuticals
Cequent is a biopharmaceutical company pioneering the development of novel therapeutics to prevent and treat a wide range of human diseases.
Conatus Pharmaceuticals
Conatus Pharmaceuticals is focused on the development of human therapeutics to treat liver failures and cancer.
Diffusion Pharmaceuticals
Diffusion Pharmaceuticals develops small molecule therapeutics for treating life-threatening medical conditions.
Immunomedics
Immunomedics is a biopharmaceutical company that specializes in developing monoclonal antibody-based products for the treatment of cancer.
Kamada
Kamada is a biopharmaceutical company engaged in developing, producing and marketing of specialty life-saving therapeutics, using a unique
Milestone Pharmaceuticals
Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.
Molecular Templates
Molecular Templates develops novel therapeutic compounds for cancer.
Palatin Technologies
Palatin Technologies, a biopharmaceutical company, develops targeted receptor specific peptide therapeutics for the treatment of diseases.
Phoenix Molecular Designs
Phoenix Molecular Designs is a biopharmaceutical company designing precise cancer therapeutics by targeting kinases.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Sequoia Sciences
Sequoia Sciences is a pharmaceutical company discovering and developing new medicines for the treatment of bacterial infections and cancers.
TARIS Biomedical
TARIS Biomedical is a pharmaceutical company developing therapies for genitourinary system issues.
TesoRx Pharma
TesoRx is a virtual pharmaceutical company developing and commercializing pharmaceutical products.
Prescient Therapeutics
Prescient Therapeutics is a biopharmaceutical company, discovers and develops novel immunotherapeutic products for the treatment of chronic.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Novartis Venture Fund
Novartis Venture Fund investment in Series C - GlycoMimetics
Sanofi Ventures
Sanofi Ventures investment in Series C - GlycoMimetics
New Enterprise Associates
New Enterprise Associates investment in Series C - GlycoMimetics
Alliance Technology Ventures
Alliance Technology Ventures investment in Series C - GlycoMimetics
Anthem Capital Management
Anthem Capital Management investment in Series C - GlycoMimetics
Novartis Venture Fund
Novartis Venture Fund investment in Series B - GlycoMimetics
Anthem Capital Management
Anthem Capital Management investment in Series B - GlycoMimetics
PTV Healthcare Capital
PTV Healthcare Capital investment in Series B - GlycoMimetics
Alliance Technology Ventures
Alliance Technology Ventures investment in Series B - GlycoMimetics
New Enterprise Associates
New Enterprise Associates investment in Series B - GlycoMimetics
Key Employee Changes
Official Site Inspections
http://www.glycomimetics.com Semrush global rank: 9.87 M Semrush visits lastest month: 93
- Host name: mi3-ts2.a2hosting.com
- IP address: 70.32.23.55
- Location: Ann Arbor United States
- Latitude: 42.2503
- Longitude: -83.8393
- Metro Code: 505
- Timezone: America/Detroit
- Postal: 48106
More informations about "GlycoMimetics"
Investor Relations | GlycoMimetics, Inc.
Oct 29, 2024 GlycoMimetics is a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers and inflammatory diseases. Our leading …See details»
GlycoMimetics - LinkedIn
GlycoMimetics | 4,084 followers on LinkedIn. At GlycoMimetics, we are committed to helping to make a difference in the lives of people living with cancers and inflammatory diseases such as …See details»
Crescent Biopharma - Crunchbase Company Profile & Funding
GlycoMimetics, Inc., a biopharmaceutical company, engages in the design and development of small molecule therapeutics to mimic the functions of bioactive carbohydrates. Its products …See details»
GlycoMimetics Company Profile | Management and Employees …
Find contact information for GlycoMimetics. Learn about their Research & Development, Business Services market share, competitors, and GlycoMimetics's email format.See details»
GlycoMimetics, Inc. Company Profile | Rockville, MD | Competitors ...
Company Description: Carbs are a good thing to GlycoMimetics. The biotechnology company uses carbohydrate chemistry to develop drug candidates for rare diseases. Its lead drug …See details»
GlycoMimetics - AnnualReports.com
GlycoMimetics is a clinical-stage biotechnology company focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from …See details»
GlycoMimetics - The Org
GlycoMimetics is committed to helping to make a difference in the lives of people living with sickle cell, cancer, and other serious diseases. Their mission is to continue to advance their research …See details»
GlycoMimetics - Overview, News & Similar companies - ZoomInfo
May 19, 2024 Who is GlycoMimetics. GlycoMimetics, Inc., a clinical stage biotechnology company, focuses on the discovery and development of glycomimetic drugs to address unmet …See details»
GlycoMimetics Company Profile - Craft
Oct 29, 2024 GlycoMimetics is a clinical-stage biotechnology company. The Company uses novel and proprietary glycobiology technology to develop treatments for diseases, particularly …See details»
Core Values - Glycomimetics
Jun 5, 2025 At GlycoMimetics, we are focused on developing treatments that provide hope for patients with cancer and inflammatory diseases. This focus is underpinned by our core values: …See details»
GlycoMimetics - Products, Competitors, Financials, Employees ...
Jan 10, 2014 Headquarters Location. 9708 Medical Center Drive Suite 1E. Rockville, Maryland, 20850, United States. 240-243-1201See details»
Glycomimetics: Function, Design, and Therapeutic Uses
Jul 23, 2025 Glycomimetics have found success in medical treatments, with some already approved for clinical use. An example is in the treatment of influenza, where neuraminidase …See details»
GlycoMimetics 2025 Company Profile: Stock Performance
Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of …See details»
GlycoMimetics, Inc. (GLYC): history, ownership, mission, how it …
GlycoMimetics, Inc. (GLYC) Market Position & Future Outlook GlycoMimetics is a clinical-stage biotechnology company focused on discovering and developing glycomimetic drugs for cancer …See details»
Harout Semerjian: I am incredibly proud to have worked
Jul 26, 2024 Source: GlycoMimetics/LinkedIn and Harout Semerjian/LinkedIn Harout Semerjian is the President, Chief Executive Officer and Director at GlycoMimetics, Inc. He is also the …See details»
GlycoMimetics (GLYC) Announces Strategic Review and Corporate ...
Jul 25, 2024 GlycoMimetics, Inc. (Nasdaq: GLYC), a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers and inflammatory …See details»
Glycomimetic drugs--a new source of therapeutic opportunities
1 GlycoMimetics Inc., Gaithersburg, Maryland 20878, USA. [email protected]; PMID: 20040279 Abstract Carbohydrates are ubiquitous and represent the most abundant class of …See details»
Strategies for the Development of Glycomimetic Drug Candidates
Improvements in binding affinity through pre-organization have been successful in a number of glycomimetics [75,76]. Pre-organization reduces the entropic penalties associated with binding …See details»
Glycomimetic - an overview | ScienceDirect Topics
24.2 Glycomimetics. In the last decades, an interesting approach that emerges and remains as a very challenging task for the development of new drugs, is the design and synthesis of …See details»
Strategies for the Development of Glycomimetic Drug Candidates
Apr 11, 2019 To enhance their usefulness as drug candidates, 'glycomimetics' have been developed: more drug-like compounds which mimic the structure and function of native …See details»